Seung Yup Paek,Sung Bae Lee,Deok Seong Park,Won Hyung Lee
申请号:
US14764116
公开号:
US09540362B2
申请日:
2014.02.19
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention relates to novel compounds of Formula 1 as sphingosine-1-phosphate receptor agonists which can be effectively used for the treatment of autoimmune diseases, a method for preparing the same, and a pharmaceutical composition comprising the same as an active component. The compounds according to the present invention are effective on extensive autoimmune diseases and chronic inflammatory diseases including relapsing-remitting multiple sclerosis, and can also be used for treating or preventing immunoregulation disorders.